{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:52:42Z","timestamp":1793224362913,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical &amp; Translational Endocrinology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcte.2024.100333","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T12:30:13Z","timestamp":1709209813000},"page":"100333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4065-6636","authenticated-orcid":false,"given":"Laurence","family":"Aoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaza","family":"Almardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fares","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Haddadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jdaidani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina","family":"Morcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Al Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Bou Sanayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliba","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Almardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Zaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcte.2024.100333_b0005","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4088\/JCP.v68n0901","article-title":"Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder","volume":"68","author":"Claudino","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.jcte.2024.100333_b0010","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4088\/JCP.v65n1104","article-title":"Topiramate in the long-term treatment of binge-eating disorder associated with obesity","volume":"65","author":"McElroy","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.jcte.2024.100333_b0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/erv.2418","article-title":"LISDEXAMFETAMINE dimesylate effects on binge eating behaviour and obsessive\u2013compulsive and impulsive features in adults with BED","volume":"24","author":"McElroy","year":"2016","journal-title":"Eur Eat Disord Rev"},{"issue":"3","key":"10.1016\/j.jcte.2024.100333_b0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.ijo.0801949","article-title":"BED: a review","volume":"26","author":"Dingemans","year":"2002","journal-title":"Int J Obes"},{"issue":"9","key":"10.1016\/j.jcte.2024.100333_b0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","article-title":"The prevalence and correlates of BED in the world health organization world mental health surveys","volume":"73","author":"Kessler","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.jcte.2024.100333_b0030","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcte.2024.100333_b0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mehy.2017.12.029","article-title":"Would glucagon-like peptide-1 receptor agonists have efficacy in BED and bulimia nervosa? a review of the current literature","volume":"111","author":"McElroy","year":"2018","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.jcte.2024.100333_b0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jdiacomp.2011.03.002","article-title":"Psychological and quality of life changes in patients using GLP-1 analogues","volume":"25","author":"Grant","year":"2011","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1016\/j.jcte.2024.100333_b0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/nyas.13467","article-title":"Disordered eating and obesity: associations between binge-eating disorder, night-eating syndrome, and weight-related comorbidities","volume":"1411","author":"McCuen-Wurst","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcte.2024.100333_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101090","article-title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","volume":"46","author":"Baggio","year":"2021","journal-title":"Molecular metabolism"},{"issue":"4","key":"10.1016\/j.jcte.2024.100333_b0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11920-012-0282-y","article-title":"Epidemiology of eating disorders: incidence, prevalence and mortality rates","volume":"14","author":"Smink","year":"2012","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"10.1016\/j.jcte.2024.100333_b0060","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/ijerph20032446","article-title":"Eating disorders and metabolic diseases","volume":"20","author":"Yu","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"10.1016\/j.jcte.2024.100333_b0065","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/acps.13356","article-title":"Longitudinal association between binge eating and metabolic syndrome in adults: findings from the ELSA-Brasil cohort","volume":"144","author":"Solmi","year":"2021","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"10.1016\/j.jcte.2024.100333_b0070","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s12325-021-01710-0","article-title":"Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists","volume":"38","author":"Ard","year":"2021","journal-title":"Adv Ther"},{"issue":"10","key":"10.1016\/j.jcte.2024.100333_b0075","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","article-title":"Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line","volume":"84","author":"Drucker","year":"1987","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jcte.2024.100333_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment","author":"Kopp","year":"2022","journal-title":"Pharmacol Res"},{"issue":"10","key":"10.1016\/j.jcte.2024.100333_b0085","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41386-019-0384-x","article-title":"Hypophagia induced by hindbrain serotonin is mediated through central GLP-1 signaling and involves 5-HT2C and 5-HT3 receptor activation","volume":"44","author":"Leon","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jcte.2024.100333_b0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J Comp Neurol"},{"issue":"10","key":"10.1016\/j.jcte.2024.100333_b0095","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.jcte.2024.100333_b0100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1037\/bul0000109","article-title":"The hippocampus and the regulation of human food intake","volume":"143","author":"Stevenson","year":"2017","journal-title":"Psychol Bull"},{"issue":"7","key":"10.1016\/j.jcte.2024.100333_b0105","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/mp.2017.91","article-title":"A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling","volume":"23","author":"Hsu","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jcte.2024.100333_b0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbr.2015.05.030","article-title":"Differential expression of CART in feeding and reward circuits in binge eating rat model","volume":"291","author":"Bharne","year":"2015","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.jcte.2024.100333_b0115","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.neuron.2012.12.002","article-title":"The role of medial prefrontal cortex in memory and decision making","volume":"76","author":"Euston","year":"2012","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.jcte.2024.100333_b0120","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1523\/JNEUROSCI.2212-10.2011","article-title":"Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function","volume":"31","author":"Barrera","year":"2011","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.jcte.2024.100333_b0125","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ijo.2011.158","article-title":"Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide","volume":"36","author":"Astrup","year":"2012","journal-title":"Int J Obes"},{"issue":"07","key":"10.1016\/j.jcte.2024.100333_b0130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/a-1844-1176","article-title":"The antiobesity effect and safety of GLP-1 receptor agonist in overweight\/obese patients without diabetes: a systematic review and meta-analysis","volume":"54","author":"Guo","year":"2022","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jcte.2024.100333_b0135","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2147\/DDDT.S58459","article-title":"Liraglutide and obesity: a review of the data so far","author":"Ladenheim","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"10.1016\/j.jcte.2024.100333_b0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2024.100333_b0145","doi-asserted-by":"crossref","DOI":"10.1177\/2042018821997320","article-title":"GLP-1 receptor agonists: an updated review of head-to-head clinical studies","volume":"12","author":"Trujillo","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jcte.2024.100333_b0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nut.2009.07.008","article-title":"Exenatide and weight loss","volume":"26","author":"Bradley","year":"2010","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.jcte.2024.100333_b0155","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3945\/ajcn.111.014837","article-title":"Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal","volume":"94","author":"Naessen","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcte.2024.100333_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.jcte.2024.100333_b0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0306-4603(82)90024-7","article-title":"The assessment of binge eating severity among obese persons","volume":"7","author":"Gormally","year":"1982","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.jcte.2024.100333_b0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4158\/EP-2019-0169","article-title":"One month weight loss predicts the efficacy of liraglutide in obese patients: data from a single center","volume":"26","author":"Maccora","year":"2020","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.jcte.2024.100333_b0175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.dsx.2020.03.009","article-title":"Dulaglutide reduces binge episodes in type 2 diabetic patients with BED: a pilot study","volume":"14","author":"Da Porto","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jcte.2024.100333_b0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fpsyt.2019.00097","article-title":"Beneficial effects of GLP-1 agonist in a male with compulsive food-related behavior associated with autism","volume":"10","author":"J\u00e4rvinen","year":"2019","journal-title":"Front Psych"},{"issue":"12","key":"10.1016\/j.jcte.2024.100333_b0185","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2174\/138161211795656774","article-title":"Pharmacological interventions for binge eating: lessons from animal models, current treatments, and future directions","volume":"17","author":"Berner","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jcte.2024.100333_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2023.100080","article-title":"Successful treatment of BED with the GLP-1 agonist semaglutide: a retrospective cohort study","volume":"7","author":"Richards","year":"2023","journal-title":"Obesity Pillars"},{"issue":"1","key":"10.1016\/j.jcte.2024.100333_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"Van Bloemendaal","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jcte.2024.100333_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101351","article-title":"GLP-1 physiology informs the pharmacotherapy of obesity","volume":"57","author":"Drucker","year":"2022","journal-title":"Molecular Metabolism"},{"issue":"2","key":"10.1016\/j.jcte.2024.100333_bib203","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.psc.2019.01.007","article-title":"Pharmacologic Treatment of Eating Disorders","volume":"42","author":"Crow","year":"2019","journal-title":"Psychiatr Clin North Am"}],"container-title":["Journal of Clinical &amp; Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:57:57Z","timestamp":1762005477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623724000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"alternative-id":["S2214623724000048"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100333","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100333"}}